XIST and osteoporosis: As previously reported, Xist is highly expressed in the serum and monocytes of patients affected with osteoporosis and induces inhibition of the osteogenic potential of bone marrow mesenchymal stem cells, inhibiting ALP, RUNX2, and osteocalcin expression [79].